80 likes | 311 Views
U.S. Therapeutic Apheresis Markets Uptake of Photopheresis in New Indications to Drive Future Revenue Growth. “The growing demand for photopheresis in off-label indications will ignite the therapeutic apheresis market, which has been in a slump in recent years.”.
E N D
U.S. Therapeutic Apheresis MarketsUptake of Photopheresis in New Indications to Drive Future Revenue Growth “The growing demand for photopheresis in off-label indications will ignite the therapeutic apheresis market, which has been in a slump in recent years.” Pharmaceutical Biotech Analyst Team Frost & Sullivan
Industry Trends • High growth in the Photopheresis Market, while the remainder of the Therapeutic Apheresis Market reports flat growth • Trend towards segregating blood banking and Therapeutic Apheresis businesses • Crossover by dialysis companies into Therapeutic Apheresis
Key Features • Frost & Sullivan provides: • Detailed insights into recent developments and trends • Drivers, restraints, challenges, and strategic recommendations • Analyst insights on ‘hot topics’ and emerging applications • in the U.S. Therapeutic Apheresis Markets • Market sizing and competitive analysis • Market forecasts and market share analysis • Pricing analysis • Product, vendor and end user analysis
What We Offer • Coverage: The United States • Proven methodology encompassing extensive primary and secondary data and research • Focused information and strategies that cover business and technology issues • Credible data and analysis highlighting industry dynamics • Winning strategies to help you create precise business plans
Who Will Benefit? Current Market Participants • Find out how you compare to the competition • Assess current and future drivers and restraints • Determine and exploit new market share opportunities New Entrants • Analyze challenges associated with the industry • Calculate time scales for strategy implementation • Position yourself to capitalize on the market’s unmet needs Investment Community • Analyze long-term strategies of therapeutic apheresis companies • Determine which participants will outperform the competition • Assess attractiveness of investing in the therapeutic apheresis market
What’s Included Existing and future markets for standard plasmapheresis, plateletpheresis, red cell exchange, leukapheresis, lipidpheresis, extracorporeal immunoadsorption and photopheresis in: • Neurology Disorders • Hematology and Oncology Disorders • Rheumatology Disorders • Other Disorders
Key Market Participants Haemonetics Corp. Hemacare Corp. Kaneka Pharma America Corp. Kansas City Community Blood Center National Blood Data Resource Center Oklahoma Blood Institute Scott & White Blood Center The Blood Center-Milwaukee Therakos, Inc. Theratechnologies, Inc. (Celmed Biosciences) Tufts-New England Medical Center - Division of Hematology/Oncology Tulane University School of Medicine-Department of Dermatology United Blood Services University Of Southern California-Photopheresis Unit Washington University School of Medicine Aethlon Medical, Inc. American Association of Blood Banks American Red Cross-Biomedical Services American Society For Apheresis America's Blood Centers B Braun Medical, Inc. Baxter Fenwal/ Baxter Healthcare Corp. BRT Laboratories Carter Bloodcare Celmed Biosciences Circe Biomedical, Inc. Cleveland Clinic-Department of Hematology and Medical Oncology Community Blood Services Of Illinois Florida Blood Services Fresenius Hemocare/ Fresenius AG Gambro BCT, Inc. Good Samaritan Regional Medical Center
For More Information • Call toll free 877 GO FROST (877.463.7876) • Fax toll free 888.690.3329 • E-mail myfrost@frost.com • Visit www.frost.com